Oral Candidiasis in Patients with Level CD4+ Below 50

Cane Lukisari; Kurnia Hayati Rahman; Nafi’ah Nafi’ah; Dwi Setianingtyas; Afryla Femilian

doi:10.18196/di.v13i1.20003

Oral Candidiasis in Patients with Level CD4+ Below 50

Cane Lukisari, Kurnia Hayati Rahman, Nafi’ah Nafi’ah, Dwi Setianingtyas, Afryla Femilian

Abstract

Approximately 90% of individuals diagnosed with HIV/AIDS have encountered Oral Candidiasis during the progression of their disease, especially in patients with a reduced CD4⁺ 200 mm³. Oral Candidiasis is a prevalent opportunistic infection of the oral cavity. Reported a case of a patient with oral candidiasis in an HIV/AIDS with CD4⁺ below 50 and discussed the mechanism of molecular relationship decreasing count CD4⁺ with virulence of Candida Albicans. In this report, we present a case of a 35-year-old female who presented with oral candidiasis. The patient's CD4⁺ count test revealed a level below 50 and HIV test I-II-III reactive. Human immunodeficiency Virus causes a decrease in CD4⁺ count and leads to opportunistic oral candidiasis infection.

Keywords

oral candidiasis; HIV; AIDS; CD4+

Full Text:

PDF

References

Femilian A, Masuku WDM, Ayuningtyas NF, Ernawati DS, Mahdani FY, Surboyo MDC. Clinical appearance of acute pseudomembranous candidiasis in children and the importance of good communication, information and education to patients: A case report. Dent J. 2022;55(2):105–8. https://doi.org/10.20473/j.djmkg.v55.i2.p105-108

Macias-Paz IU, Pérez-Hernández S, Tavera-Tapia A, Luna-Arias JP, Guerra-Cárdenas JE, Reyna-Beltrán E. Candida albicans the main opportunistic pathogenic fungus in humans. Rev Argent Microbiol 2022;55(2):189–98. https://doi.org/10.1016/j.ram.2022.08.003

Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines. J Clin Exp Dent. 2015;7(3):e419–27. https://doi.org/10.4317/jced.52127

Murtiastutik D, Prakoswa CRS, Tantular IS, Ervianti E, Hidayati AN, Listiawan MY. Correlation between CD4 T lymphocyte and candida species counts in oral candidiasis patients with HIV / AIDS. Indian J Forensic Med Toxicol. 2021;15(1):1013–20. https://doi.org/10.37506/ijfmt.v15i1.13548

Ersha RF, Ahmad A. Human Immunodeficiency Virus – Acquired Immunodeficiency Syndrome dengan Sarkoma Kaposi. J Kesehat Andalas. 2018;7(Supplement 3):131. https://doi.org/10.25077/jka.v7i0.875

Kirti YK. Prevalence of Oral Candidiasis in Indian HIV Sero-Positive Patients with CD4 + Cell Count Correlation. Indian J Otolaryngol Head Neck Surg 2019;71(1):124–7. https://doi.org/10.1007/s12070-018-1342-3

Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG. Manipulation of dendritic cell function by viruses. Curr Opin Microbiol. 2010;13(4):524–9. https://doi.org/10.1016/j.mib.2010.06.002

Garg H, Mohl J, Joshi A. HIV-1 induced bystander apoptosis. Viruses. 2012;4(11):3020–43. https://doi.org/10.3390/v4113020

Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, Harris LD, et al. Loss of CD103+ Dcs and Mucosal IL-17+ and IL-22+ Lymphocytes is Associated with Mucosal Damage in SIV Infection. 2013;5(6):646–57. https://doi.org/10.1038/mi.2012.38

Miró MS, Caeiro JP, Rodriguez E, Vargas L, Vigezzi C, Icely PA, et al. Candida albicans Modulates Murine and Human Beta Defensin-1 during Vaginitis. J Fungi. 2022;8(1):1–18. https://doi.org/10.3390/jof8010020

Mengesha BG, Conti HR. The role of IL-17 in protection against mucosal Candida infections. J Fungi. 2017;3(4). https://doi.org/10.3390/jof3040052

Urban CF, Nett JE. Neutrophil extracellular traps in fungal infection. Semin Cell Dev Biol. 2019;89:47–57. https://doi.org/10.1016/j.semcdb.2018.03.020

Burket LW. Burket’s Oral Medicine. thirteenth. Glick M, Greenberg MS, Lockhart PB, Challacombe SJ, editors. Newyork, USA: Wiley Blackwell; 2021.

Radithia D, Soebadi B, Hendarti HT, Surboyo MDC, Ayuningtyas NF, Triyono EA. Dental-related problems and oral manifestation of hiv/aids patients in soetomo general hospital surabaya. Bali Med J. 2020;9(2):537–41. https://doi.org/10.15562/bmj.v9i2.1291

Ghom AG. Textbook of Oral Medicine. Jaypee Brothers Medical Ltd; 2014.

16. Desai J V. Candida albicans hyphae: From growth initiation to invasion. J Fungi. 2018;4(1). https://doi.org/10.3390/jof4010010

Henriques M, Silva S. Candida albicans virulence factors and its pathogenicity. Microorganisms. 2021;9(4):11–3. https://doi.org/10.3390/microorganisms9040704

Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi. 2021;7(2):1–19. https://doi.org/10.3390/jof7020079

Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: A disease of opportunity. J Fungi. 2020;6(1):1–28. https://doi.org/10.3390/jof6010015

Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022;13(1):89–121. https://doi.org/10.1080/21505594.2021.2019950

Li W, Yu D, Gao S, Lin J, Chen Z, Zhao W. Role of Candida Albicans-secreted aspartyl proteinases (Saps) in severe early childhood caries. Int J Mol Sci. 2014;15(6):10766–79. https://doi.org/10.3390/ijms150610766

Zand F, Zahed L, Mansouri P, Dehghanrad F, Bahrani M, Ghorbani M. The effects of oral rinse with 0.2% and 2% chlorhexidine on oropharyngeal colonization and ventilator associated pneumonia in adults’ intensive care units. J Crit Care. https://doi.org/10.1016/j.jcrc.2017.02.029

Somayaji S, Gadahad MR, Lakshminarayana S. Antimicrobial efficacy of chlorine dioxide against Candida albicans in stationary and starvation phases in human root canal: An in-vitro study. Sahel Med J. 2014;17(1):1. https://doi.org/10.4103/1118-8561.129144

Rai A, Misra SR, Panda S, Sokolowski G, Mishra L, Das R, et al. Nystatin Effectiveness in Oral Candidiasis Treatment: A Systematic Review & Meta-Analysis of Clinical Trials. Life. 2022;12(11). https://doi.org/10.3390/life12111677

DOI: https://doi.org/10.18196/di.v13i1.20003